Customer reviews paint a compelling picture of satisfaction and tangible results
ACTIVE CLINICAL TRIALS There are currently 2 clinical trials registered on Clinicaltrials.gov regarding the development of cagrilintide in people with overweight or obesity
While GLP-1s are effective at suppressing appetite and reducing food intake in the short term, emerging research raises concerns about weight cyclingthe repeated loss and regain of weightwhich is both common and biologically driven after discontinuation
That means the vast majority of weight lost, approximately 77%, was fat
Dose range offered: 250 to 500 mcg per capsule
Summary: People are accessing retatrutide through unregulated online suppliers, overseas compounding pharmacies, and social media networks, though the only lawful route in the UK is participation in an approved clinical trial